| Dear Voornaam
When we first reported on who applies for, and is awarded, our research funding in 2021, we committed to taking action to create a more inclusive and diverse research community. Two years on, were making progress. Overall success rates for men and women who apply for our funding are equal, were receiving increasing numbers of fellowship applications from people from ethnic minority backgrounds and were providing targeted support to encourage more Black students into cancer research.
While its good to see progress in the right direction, were not satisfied with the way things are. Now, as we report on our latest funding data, were also talking about the programmes weve introduced to support diversity at all stages of the research career pipeline. To drive change, our initiatives are removing barriers to participation at school and supporting the development of our leaders. And weve implemented positive action schemes to increase the equality of opportunity and experience at all career stages. Were proud to partner with some great organisations on these initiatives, and we hope youre inspired by the stories of the people weve worked with.
You can discover our latest data and read more about our work in our report.
Kind regards,
Iain Foulkes
Executive Director Research & Innovation
CEO Cancer Research Horizons
Cancer Research UK |
|
|---|
|
|---|
|
|
Funding & Research Opportunities |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
MEET ABENA AMPONSAH, ONE OF OUR FIRST BLACK LEADERS IN CANCER PHD STUDENTS Ahead of starting her PhD on our Black Leaders in Cancer Scholarship Programme in September, Abena Amponsah talked to us about her motivation for working in cancer research, what attracted her to our programme and her advice to those considering applying.
These programmes help cultivate a sense of belonging, which I believe will empower and inspire more Black students to aim higher and achieve their full potential, says Abena.
For her research project, Abena will explore how mechanical properties of the extracellular matrix influence immune cell response and cancer cell invasion to identify new targets for therapeutic interventions.
|
|
|---|
|
|---|
|
|
JOIN US TO DISCUSS INEQUALITIES IN CANCER DETECTION AND DIAGNOSIS At our global early detection conference this October, Kate Brain (Cardiff University) and Carmen Guerra (University of Pennsylvania) will chair a session on how to address the disparities between groups separated by ethnicity, gender, socioeconomic status and geography.
Take part in the session to discuss the reasons for and mechanisms of these differences, their impact on timeliness of detection and the interventions to reduce these inequalities.
Our three-day event, run in collaboration with the Canary Center at Stanford and OHSU Knight Cancer Institute, is packed with sessions to explore and debate opportunities in cancer early detection.
|
|
|---|
|
|---|
|
|
CANCER RESEARCH HORIZONS PARTNERS WITH TWIST BIOSCIENCE Our innovation arm, Cancer Research Horizons, has partnered with Twist Bioscience, a biotechnology company that provides antibody discovery solutions based on their expertise in DNA synthesis.
The partnership grants Cancer Research Horizons access to Twists extensive phage display libraries for five years, which will greatly enhance its antibody discovery capabilities.
We look forward to using this technology to accelerate the delivery of high-quality therapeutics and diagnostics to cancer patients, said Hamish Ryder, CEO of Therapeutic Innovation at Cancer Research Horizons. |
|
|---|
| SHARE YOUR EXPERIENCE OF UK CLINICAL RESEARCH Thank you to everyone whos already completed our survey on delivering and supporting clinical research in the UK. Your insights will help shape the policy calls on the UK clinical trial environment in our upcoming Manifesto for Cancer Research and Care.
The challenges affecting clinical research in the UK impact all disease areas, so were interested in hearing from a broad range of specialisms. Please consider sharing our survey with your colleagues and networks beyond oncology. |
|
|---|
|
|---|
|
|
BECOME A TRUSTEE FOR THE SCIENCE MEDIA CENTRE The Science Media Centre is calling for both emerging research leaders and researchers in senior strategic positions to join its board of trustees.
Trustees provide overarching governance, guidance on strategic direction and advice on how to respond to controversial, challenging or sensitive issues. And your work will contribute to the SMCs mission to disseminate accurate, reliable and evidence-based information about science through the media.
Applications are open until 4 September.
|
|
|---|
|
|---|
|
|
DETERMINE: A UNIQUE APPROACH TO RUNNING RARE CANCER TRIALS There are far fewer treatments available for people with rare cancers but how do you address this unmet clinical need?
The DETERMINE trial offers a unique solution to this question. As the UKs first national precision medicine trial for rare cancers, DETERMINE allows patients to access off-label treatments in the context of a clinical trial, which not only streamlines access to potential treatments but also enables investigators to collect valuable data to benefit many more people with rare cancers in the future.
Cancer Research Horizons has played a crucial role in identifying and securing multi-pharma partnerships, bridging the gap between academia and industry to provide the targeted drugs used for evaluation across the trial.
The value of the trials cross-sector and collaborative approach has already been recognised through two awards. |
|
|---|
|
|---|
|
|
| | | Cambridge, UK 14 September 2023 |
|
|---|
|
|---|
| | | Online 4:00 PM 27 September 2023 |
|
|---|
|
|---|
| | | Paris, France 04 October 2023 |
|
|---|
|
|---|
| | | London, UK 10 October 2023 |
|
|---|
|
|---|
| | | Liverpool, UK 18 October 2023 |
|
|---|
|
|---|
| | | Manchester, UK 03 November 2023 |
|
|---|
|
|---|
| | | London, UK 14 November 2023 |
|
|---|
|
|---|
| | | London, UK 21 November 2023 |
|
|---|
|
|---|
| | | Manchester, UK 27 February 2024 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
